Physician profile
Muhammad Azharuddin
NPI 1669867024
$3,984.44
in general payments reported to CMS, 2019-2025
35 companies · $1,000 in 2025
The $1,000 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.66 · 2021: $174 · 2022: $215 · 2023: $740 · 2024: $1,762 · 2025: $1,000.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,301 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,301.47 |
| Education | $199.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,140.13 | 2019-2025 | Erleada, Akeega, Rybrevant |
| Astrazeneca Pharmaceuticals LP | $355.01 | 2022-2025 | Calquence, Lynparza, Imfinzi |
| Pfizer INC. | $332.98 | 2022-2025 | |
| Dendreon Pharmaceuticals LLC | $313.14 | 2024-2025 | Provenge |
| Merck Sharp & Dohme LLC | $221.67 | 2022-2025 | Keytruda, Welireg, Keytruda Qlex |
| Beigene USA, INC. | $155.29 | 2021-2024 | Brukinsa |
| Telix Pharmaceuticals | $151.28 | 2024 | Illuccix |
| Tempus Ai, INC | $139.45 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $130.50 | 2025 | Libtayo |
| Exelixis INC. | $121.69 | 2023 | Cabometyx |
| E.R. Squibb & Sons, L.L.C. | $88.07 | 2022-2025 | Opdivo |
| Bayer Healthcare Pharmaceuticals INC. | $81.95 | 2024-2025 | |
| Spectrum Pharmaceuticals INC. | $70.56 | 2024-2025 | Rolvedon |
| Emd Serono, INC. | $61.09 | 2024-2025 | |
| Genzyme Corporation | $53.18 | 2022-2024 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $48.04 | 2024 | Orgovyx |
| Blue Earth Diagnostics | $41.57 | 2024 | |
| Gilead Sciences, INC. | $37.24 | 2024 | |
| Novartis Pharmaceuticals Corporation | $36.86 | 2024-2025 | |
| Puma Biotechnology, INC. | $36.31 | 2024-2025 | |
| Accord Healthcare, INC. | $35.06 | 2022 | |
| Rigel Pharmaceuticals, INC. | $33.89 | 2024 | Tavalisse, Rezlidhia |
| Sirtex Medical INC | $32.06 | 2024 | Sir-Spheres Microspheres |
| Amgen INC. | $30.63 | 2019-2024 | Prolia, Evenity |
| Deciphera Pharmaceuticals INC. | $29.56 | 2025 | Qinlock, Tgct |
| Glaxosmithkline, LLC. | $29.36 | 2024 | Ojjaara |
| Takeda Pharmaceuticals U.S.A., INC. | $23.86 | 2025 | Ninlaro |
| Endo USA, INC. | $21.87 | 2024 | Aveed, Xiaflex |
| Stemline Therapeutics INC. | $21.68 | 2025 | Orserdu |
| Abbvie INC. | $20.58 | 2024 | |
| Astellas Pharma US INC | $20.38 | 2022 | |
| Tolmar, INC. | $19.12 | 2025 | Rubraca, Eligard |
| Pharmaand Gmbh | $19.12 | 2025 | Rubraca |
| Ge Healthcare | $15.83 | 2025 | |
| Foundation Medicine, INC. | $15.43 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Azharuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.